TRAZODONE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trazodone Hydrochloride, and when can generic versions of Trazodone Hydrochloride launch?
Trazodone Hydrochloride is a drug marketed by Accord Hlthcare, Alvogen, Am Therap, Apotex, Apotex Inc, Aurobindo Pharma, Fosun Pharma, Mylan, Mylan Pharms Inc, Oxford Pharms, Pliva, Quantum Pharmics, Rising, Sun Pharm Industries, Teva, Teva Pharms Usa, Torrent, Usl Pharma, Watson Labs, and Zydus Pharms. and is included in twenty-nine NDAs.
The generic ingredient in TRAZODONE HYDROCHLORIDE is trazodone hydrochloride. There are fourteen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trazodone Hydrochloride
A generic version of TRAZODONE HYDROCHLORIDE was approved as trazodone hydrochloride by APOTEX on March 25th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRAZODONE HYDROCHLORIDE?
- What are the global sales for TRAZODONE HYDROCHLORIDE?
- What is Average Wholesale Price for TRAZODONE HYDROCHLORIDE?
Summary for TRAZODONE HYDROCHLORIDE
![TRAZODONE HYDROCHLORIDE drug patent expirations Drug patent expirations by year for TRAZODONE HYDROCHLORIDE](/p/graph/s/t/TRAZODONE_HYDROCHLORIDE-patent-expirations.png)
Recent Clinical Trials for TRAZODONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Simon Ducharme, MD | Phase 3 |
Alzheimer's Drug Discovery Foundation | Phase 3 |
University of New Mexico | Phase 4 |
Pharmacology for TRAZODONE HYDROCHLORIDE
Drug Class | Serotonin Reuptake Inhibitor |
Medical Subject Heading (MeSH) Categories for TRAZODONE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for TRAZODONE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for TRAZODONE HYDROCHLORIDE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
OLEPTRO | Extended-release Tablets | trazodone hydrochloride | 150 mg and 300 mg | 022411 | 1 | 2010-10-18 |
US Patents and Regulatory Information for TRAZODONE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | TRAZODONE HYDROCHLORIDE | trazodone hydrochloride | TABLET;ORAL | 070857-001 | Oct 10, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva | TRAZODONE HYDROCHLORIDE | trazodone hydrochloride | TABLET;ORAL | 074357-001 | Apr 30, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Zydus Pharms | TRAZODONE HYDROCHLORIDE | trazodone hydrochloride | TABLET;ORAL | 205253-001 | Oct 10, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Rising | TRAZODONE HYDROCHLORIDE | trazodone hydrochloride | TABLET;ORAL | 072484-001 | Apr 30, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |